OBIGEN PHARMA INC.
Ownership & governance
Executives 5Directors 7Avg age 58Avg tenure 2.8y
PC
Pei Fen Chou
Chief Executive Officer
Age 58Since 2025-03-17Profile →
+11
Executives5
Board of directors7
CY
Chong-Yao Yin→
Director/Board Member
—Since 2021-03-31
PC
Pei Fen Chou→
Director/Board Member
Age 58Since 2025-03-17
HW
Hui Jun Wang→
Chairman
—Since 2023-12-28
HM
Hai Yi Ma→
Director/Board Member
—Since 2021-04-25
HC
Hsin Min Chen→
Director/Board Member
—Since 2021-04-25
KK
Kuo Lin Kao→
Director/Board Member
——
WT
Wan Fang Ting→
Director/Board Member
——
Catalog · 2026-07-09
Registry officers12
| Name | Role | Since | Shares |
|---|---|---|---|
| Chia Jung Chuang | Director of Finance/CFO | 2025-04-08 | - |
| Hui Jun Wang | Chairman | 2023-12-28 | - |
| Meiling Jiang | Chief Administrative Officer | 2023-11-30 | - |
| Pei Fen Chou | Chief Executive Officer | 2025-03-17 | - |
| Yongkai Wang | Chief Tech/Sci/R&D Officer | 2025-05-15 | - |
| Chong-Yao Yin | Director/Board Member | 2021-03-31 | - |
| Hai Yi Ma | Director/Board Member | 2021-04-25 | - |
| Hsin Min Chen | Director/Board Member | 2021-04-25 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus none
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.